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Histopathological and Laboratory
Assessment of Visual Dysfunction
by Ralph Heywood*
The currently available methods of assessing ocular toxicity are discussed. Manifestations of
ocular toxicity are best described clinically; histopathological examination of the eye is beset
with problems of preparing the eye for morphological examination. Electron microscopy is
essential to look for chemically induced side effects at the cellular level. Mechanisms of ocular
toxicity are poorly understood, and the limitation of animal studies in predicting side effects in
man must be appreciated.
The concept ofchemical damage to the eye, with
effects on vision, is one of the sensitive areas of
current toxicology. Because of the problems of
adverse reactions it is now required that new
chemicals are tested for safety before their general
release. Animal studies are essentially compara-
tive, in that spontaneous and induced pathological
manifestations are compared in control and treated
animals, respectively. The purpose is to identify
variations from normal and to define underlying
disturbances ofphysiological mechanisms. The con-
ventional procedure for toxicity studies is to have a
control group and three groups of animals given
different dose levels of a compound, in order to
identify target organ systems and to define no
observable effect levels. The regulatory authorities
stipulate that these studies must be carried out in a
rodent and anonrodent species. The purpose ofthis
paper is to outline the methods for assessing ocular
damage in the commonly used laboratory species,
followingsystemicadministrationofchemicals, with
particular reference to underlying mechanisms of
toxicity, and to draw attention to the limitations
both in the use of, and understanding of, these
approaches to safety evaluation.
The overwhelming number of reports on ocular
toxicity (1-5) gives the impression that the eye is a
potential target organ of every chemical ever
discovered. The interpretation of these reports
must be kept in perspective.
*Huntingdon Research Centre, Huntingdon, Cambridgeshire,
PE18 6ES, England.
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Examination of the Eye
Ocular toxicity can be monitored by using a
variety of techniques: those applicable to animals
are listed in Table 1. Because toxicological studies
concern groups of animals, the techniques adopted
mustbesimpleandapplicable totheunanaesthetized
animal. Examination ofthe eye may be by direct or
indirect ophthalmoscopy, although indirect ophthal-
moscopy is preferred. Slit-lamp biomicroscopy is
not recommended in the routine ophthalmoscopic
examination. Tear flow can be measured by using
commercially available Schirmer tear-test papers.
Intra-ocular pressure can be measured either by
using the Schiotz' tonometer or preferably, an
applanation tonometer.
Functional examination is limited to the testing
of the simple reflexes-the fixating reflex, the
Table 1. Examination for ocular toxicity.
General examination












35corneal reflex, the blink reflex and the pupillary
light reflex. The fixating and blink reflexes are
dependent on the afferent pathways of the optic
nerve, optic tract, lateral geniculate body, optic
radiation and visual cortex. The efferent pathway is
via the superior colliculus, the third, fourth and
sixth cranial nerves, and cervical nerves. Constric-
tion of the pupil is dependent on the optic nerve,
optic tract, pretectal region with the efferent
pathway, the third parasympathetic division, cili-
ary ganglion and nerve. The consensual response is
dependent on decussations in the optic chiasma.
Physiological measurement of retinal integrity
can be made by recording electroretinograms. The
electroretinogram represents the summated tran-
sient electrical activity evoked inresponse to alight
stimulus, of a large number of retinal cells. It is
now generally accepted that the outer layers ofthe
retina give rise to the initial negative deflection, or
a wave, while the activity ofthe inner layers ofthe
retina is represented by the subsequent positive
deflection, or b wave. The later positive potential,
or c wave, is thought to originate in the pigment
epithelium. The pattern ofresponse ofthe rod and
cone systems are known to differ, the cones having
ahigher stimulusthreshold than the rods. Brunette
and Lafond (6) have demonstrated, in rhesus mon-
keys, that when stimuli ofhigh intensity are used,
the rod and cone responses are superimposed, and
that a pure rod response is obtained only by using
low-intensity stimuli after complete dark adapta-
tion. The validity of the results obtained from an
electroretinographic examination relies heavily on
the minimization of all artifacts and the standard-
ization of the recording technique. Subtle changes
inthe electroretinograms recorded during, orafter,
treatment ofexperimental animals with novel com-
pounds must be interpreted with caution and
assessed in conjunction with other clinical and
ultrastructural histopathological findings. Without
close correlation with behavioural or morphological
evidence, changes in the electroretinogram are not
necessarily attributable to disturbance of visual
function. The value of the electroretinographic
examination in predictive chemical safety evalua-
tions lies in the provision of supplementary evi-
dence to confirm or refute ophthalmological assess-
mentsbased onconventionalclinicalandpathological
data.
Considerable problems are encountered in pre-
paring eyes for morphological examination. Imme-
diately after the animal has been killed, the eyes
should be dissected from the orbits by using the
technique described by Saunders and Jubb (7) and
placed in a fixative. It is essential to use a fixative
whichwillrapidlypenetratethesclera. Zenkers-acetic
36
imposes critical timing but gives good results for
the retina. Bouin's fluid is considered to be better
for fixing the lens. The fixation, however, most
appropriate forroutine toxicological laboratories, is
Davidson'sfluid. Formalinfixationinevitablycauses
separation of the retinal layers in the rat. It is
difficult to avoid inducingartifacts in the taking and
fixing of eyes. After fixation, the calottes are
removed and the eye embedded in fibro-wax. It is
useful ifthe eye can be correctly orientated before
sectioning: this can sometimes be donebyreference
to the ocular muscles and/or by marking the cornea
before fixation. Sagittal sections are cut at 5 ,um
and stained with hematoxylin and eosin. For elec-
tron microscopy, the eyes are fixed in sodium
cacodylate buffered glutaraldehyde for 5 min. The
cornea is then removed and the globe returned to
the glutaraldehyde for a further 5 min, after which
the iris is removed and the eye allowed to fix for a
further 10 min. The lens and vitreous are then
removed from the cup, which is allowed to fix for a
further45min. Theretinais subsequentlypost-fixed
in 2% osmium in cacodylate buffer for 1 hr before
beingdehydrated in alcohol and embedded in epoxy
resin.
It is necessary to know the range of normal and
spontaneous pathological variations common to the
test species. In the dog, rat and primate, many
spontaneous abnormalities occur congenitally, or as
a result of trauma, infection or developmental and
ageing processes.




the eyelids or affect lachrymal secretion.
Ptosis of the eyelids, although a common sign in
acutely intoxicated rats, is rarely observed follow-
ing chronic administration ofcompounds. Edema of
the eyelids is occasionally seen, often associated
with nonsteroidal anti-inflammatory agent adminis-
tration. Paracetamolintoxication inthe doginduced
palpebraledemaatthedosagelevelcf450mg/kg/day
with an associated reduction in the secretory activ-
ity of the meibomian glands. The dog has a third
eyelid, which is extensive and can cover the whole
anterior aspect ofthe eye; compounds affecting the
autonomic system can cause relaxation ofthis third
eyelid.
Conjunctival alterations aremostfrequentlycaused
by changes in the lachrymal secretion and usually
involve the cornea.
Environmental Health PerspectivesThe secretion of red tears in the rat, chromo-
dacryorrhea, is mainly associated with stress fac-
tors, oranovergrowth oftheincisorteeth. Harkness
and Ridgway (8) have shown that injections of
acetylcholine increased almost instantaneously the
flow of a dull red secretion, the red color being
caused by porphyrins.
Keratoconjunctivitis sicca has been induced in
dogsbyphenazopyridinehydrochloride (9)and some
sulfonamides (10); the hypotensive agent, clonidine,
has recently been found to induce keratoconjuncti-
vitis sicca in the rat (11). All anticholinergic com-
pounds given in high dose levels induce keratocon-
junctivitis sicca, particularly in the dog. Secretion
of lachrymal fluid is not exclusively parasympa-
thetic in origin: stimulation ofthe sympathetic sys-
tem also plays a part, and this accounts for the
occasional cases ofdry eye, seen in dogs given high
doses of beta-adrenergic receptor blocking agents.
These conditions of the adnexa are best diag-
nosed by clinical examination, and, where appro-
priate, supported byevidence ofreduced tearsecre-
tion.
Cornea
For a systemically administered compound to
affect the cornea it must be secreted in the tears or
pass the blood-aqueous barrier. Epithelial erosions
are the simplest form for the damage to take, but
with continued insult the superficial lesions rapidly
can progress to keratitis ofvarying severity. Some
compounds canreach concentrations withinthe aque-
ous humor sufficient to damage the corneal endo-
thelium. Ifdamage does occur, the stromal swelling
becomes apparent in the whole cornea and the eye
appears white and bulges from the orbit. Corneal
opacities can be induced in laboratory animals by a
variety of compounds, in the rat invariably by
morphine (12) or the narcotic analgesics (13). Lipoi-
dal opacities induced by a nitroaniline have been
described in the dog (14).
Exacerbation of traumatic lesions and reactiva-
tion of old infections can be induced following the
administration of steroids.
Toxicity involving the cornea is best diagnosed
byclinical examination supported byhistopathological
examination of the cornea.
Uveal Tract
A side effect ofmany chemicals is the disturbance
ofthe refractive power ofthe eye and the ability of
the eye to accommodate. The common response of
the pupil is dilation or constriction. Dilation of the
pupil is induced by the systemic administration of
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anticholinergic compounds and parasympatholytic
agents: constriction is by direct cholinergic or para-
sympathomimetic action. The effects on the pupil
can be modified by central effects.
The high vascularity of the uveal tract should
make this a potential site for chemical immunologic
reactions. However, this has not been the case, and
in my experience one compound only, an antiviral
agent, caused sensitization of the uveal tract in a
subhuman primate species, with resultant uveitis.
Lens
The lens arises from ectoderm. It is a biconvex
transparent body, separating the aqueous and vit-
reous chambers. It has no blood supply and relies
on the aqueous and, to a lesserextent, the vitreous,
for its supply of nutrients. The lens continues to
grow through life by layering new fibers over the
old fibers, so that the old cells become compressed
into the center. The lensundergoes aprogression of
age-related changes and may also develop opaci-
ties. The characteristic response to injury is degen-
eration.
For a compound to be cataractogenic it must
traverse the blood-aqueous barrier to enter the
anterior chamber. Toxic levels can be achieved only
by high daily dosage, slow excretion or prolonged
administration. The selective entrance ofdrugs into
the aqueous is dependent on molecular size and
lipid solubility. Large molecules are held back by
the capillary membrane. Lipid-soluble substances
rapidlytraversetheblood-aqueous barrierandreach
equilibrum.
Chemicallyinduced lenticularlesions are cataracts
and can be classified into two major groups: tran-
sient lens opacities and permanent cataracts.
TransientLens Opacities. Opacities ofa tran-
sient nature, in which the lens returns to normal
within a few hours, have been produced in young
rats followingthe administration ofsubstituted phe-
nothiazines, catecholamines andmorphine-like anal-
gesics. Transient lens opacities have been produced
in young Beagle dogs following the administration
ofsometranqullizers, some diuretics and diisophenol.
These opacities are usually associated with the
anterior capsule, where they appear as crescents
around the periphery of the lens, or as discrete
opacities on the anterior surface ofthe lens (Fig. 1).
These acute reversible lens opacities are ascribed
primarily to changes in the osmolality of the aque-
ous humor, although other factors may be involved.
PermanentCataracts. Theclinicaldevelopment
of permanent chemically induced cataracts follows
distinct courses. There is always a latent period
between the administration of a compound and the
37FIGURE 2. Opacification of superficial lens fibers.
onset oflenticular change, and this can vary from a
few days to several months. Many cataracts start at
the equator of the lens. The first sign is the
appearance of vacuoles and striation around the
equator ofthelens. The lens atthe equatorbecomes
opaque and appears to have a surrounding halo.
Opacification ofthe superficial lens fibers continues
and extends under the anterior or, more frequent-
ly, the posterior capsule of the lens. Initially, only
those lens fibers immediately below the capsule are
involved (Fig. 2). The most common form ofchemi-
cally induced cataract is that which starts at the
posterior pole of the lens. In the dog, these cata-
racts appear roughly triangular at the posterior
pole, involving only subcapsular fibers (Fig. 3). In
the rat, chemically induced cataracts show a vari-
ety of morphological patterns, but often they first
show as triangular opacities at the posterior pole.
The most likely explanation ofthe greater involve-
ment of the posterior cortex of the lens in toxic
cataracts is because posteriorly the capsule is thin-
ner and epithelial cells are absent, allowing the
toxic agent to penetrate into the superficial fibers
more readily. At the posterior pole the lens is at its
greatest stress with respect to nutrients and oxy-
gen. The only other manifestation oflenticular tox-
icity that has been shown is that of a changes in
refraction. Changes in the transparency as well as
therefraction ofthe lensnucleus havebeenrecorded
followingthe administration ofDMSO (15) and with
p-chlorophenylalanine (16).
Cataracts are best diagnosed by clinical examina-
tion; processing of the lens for histopathological
examination is of very limited value. Chemicals
with widely differing structures and pharmacologi-
cal activity have beenreported to cause cataracts in
laboratory animals. Theseagentshavebeenreviewed
by Gehring (17). Such compounds defy easy class-
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FIGURE 3. Triangular posterior polar subcapsular opacity.
ification because the mechanisms oftheir cataracto-
genicity are poorly understood.
Cataracts can be induced by feeding high levels
of galactose and xylose to rats. Animals made dia-
beticbytheadministration ofalloxanorstreptozotocin
or those with high dose levels of progestational
agents develop cataracts. Here the common mech-
anism is the formation of sugar alcohols which
accumulate; because they are not easily metabo-
lized they cause hypertonicity and osmotic swell-
ing. Those alkylatingagentsthatarecytotoxicinduce
cataracts by interfering with cell proliferation.
Triparanol, a drug once used in the treatment of
hypercholesterolaemia, induces cataracts in the rat
and the dog. The opacities appear as peripheral
striateopacities, and sudanophilicmaterialhasbeen
identified within the lens fibers. It is possible that
this type of cataract is a manifestation of phospho-
lipidosis, Thecataractsinduced byothercompounds,
such as the sulfonylurea drugs, the chelating agent
desferrioxamine, sulfonamides, the steroids such as
Environmental Health Perspectives
FIGURE 1. Transient lens opacity.methallibure and clomiphene citrate, and chemicals
such asdiquat, heptachlorandmirex, areofunknown
mechanisms. Many ofthe agents inducing cataracts
may do so by specific interference with enzyme
systems. The toxic effects ofvarious substances on
the lens are quantitatively very different in differ-
ent species.
Retina
The response of the ocular fundus to chemical
insult can be classified into three main categories:
hemorrhage; the presence of exudates; and degen-
erative changes.
Compounds which cause hemorrhage do so by
acting directly or indirectly on the clotting mecha-
nism. The blood frequently penetrates the hyaloid
membrane and appears in the vitreous as blobs or
clots.
Exudates are caused by the escape of plasma
and/or white blood cells from defective blood ves-
sels. Exudates between the pigment epithelium
layer and the rod and cone layer can cause partial
detachment of the retina (Fig. 4). The quinines,
such as imidazoquinazoline and quinine sulfate, can
induce this type ofchange in the dog (18). Occasion-
ally, the compound or a metabolite ofthe compound
can be found to leak from retinal vessels.
Thedrug-inducedretinopathieshavebeenreviewed
byMeier-Ruge (19), withthemaindiscussion directed
towardstheantimalarialchloroquine, andthepsycho-
tropic phenothiazine derivatives. Ofthe three cate-
goriesofphenothiazines, onlythepiperidinesinduce
retinal lesions. Of these compounds, thioridazine
has been most extensively studied. Retinal lesions
can be readily induced with these compounds in the
cat and dog; on examination, the retina of the
tapetum has a coarse spotted appearance (Fig. 5).
The lesions first occur in the primary visual cells,
with secondary changes in the pigment epithelium.
FIGURE 4. Retinal detachment: dog. FIGURE 5. Thioridazine toxicity: dog.
April 1982 39Meier-Ruge (20) has shown by histochemical tech-
niques that there is a massive loss ofenzyme activ-
ity in the ellipsoids of the rods. He is also of the
opinion that the absorbent binding to melanin is of
importance.
Experimental chloroquineretinopathyhascaused
considerable controversy over the mechanisms of
the toxicity. It is certain that chloroquine binds to
the pigmented tissues ofthe eye (19, 21-23), but it
is doubtful whether the pigment binding is ofrele-
vance to the primary retinopathy. From work car-
ried out in the albino rat and pigmented strains,
rabbits, beagle dogs, cats and the rhesus monkey,
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the initial reaction of the retina is the formation of
membranouscytoplasmic bodies (myelinoidbodies),
and these myelinoid bodies can be induced within
one week of starting treatment (Fig. 6). Rosenthal
et al. (23) clearly demonstrated that degenerative
changes in the eye of the monkey occur in the
nucleus and cell body ofboth the rods and cones and
that the pigment epithelial damage was a later
manifestation ofchloroquine toxicity. In this exper-
iment in the rhesus monkey, very extensive dam-
age occurred in the retina, although there was no
clinical or functional evidence of change.
Thebindingcapacity ofthe pigment tissues ofthe
FIGURE 6. Myelinoid bodies. Ganglion cells of rat retina following 5 doses of 100 mg/kg/day ofchloroquine. x 14,300.
Environmental Health Perspectiveseye have been demonstrated for many compounds
besides chloroquine and the phenothiazines. The
beta-blockers, rifampicin, many antiprotozoals, tet-
racyclines, glycosides andmostpolycyclic compounds
bind to melanin. Compound uptake apparently
increases with time, and once bound to melanin it
can be retained for long periods. With the majority
ofcompounds there is no resultant retinal toxicity,
presumably because the compound is bound in an
inactive form. In some cases, as with some pheno-
thiazines and chloroquine, once the binding capac-
ity has been exceeded, direct damage may result.
There are few reports of drug-induced retinal
toxicity in the rat. Cyproximide, a psychotropic
agent (24), a propionic acid derivative (25) and a
nitrosourea (26) have been recorded as inducing
retinopathies in the rat.
The administration ofamphophilic compounds to
the rat results in the formation ofmyelinoid bodies
in many cell types. These myelinoid bodies are
uni- or multicentric. They are particles limited by a
single membrane and containing osmiophilic mem-
branes in concentric arrangement.
The formation ofmyelinoid bodies is a manifesta-
tion of chemically induced lysosomal storage dis-
ease. Generalizedphospholipidosishasbeeninduced
by a variety of chemical agents which include anti-
histamines, hypolipidemics, anti-inflammatories, anti-
depressants, anorectics and coronary vasodilators
(27, 28). In chemical safety evaluation studies it has
FIGURE 7. Normal tapetal cells: dog. x 20,200.
April 1982 41been the drug-induced pulmonary lipidosis with the
accumulation offoamy macrophages which has pro-
moted interest. Drenckhahn and Lullmann-Rauch
(29) have focused attention on drug-induced retinal
lipidosis, which has been caused by several com-
pounds. Myelinoid bodies have been found in the
inner retinal cell types and the pigment epithelium.
Different compounds have given different distribu-
tions: some compounds, like triparanol, have shown
a predeliction for pigment epithelial cells, while
chloroquine affects mainly the ganglion cells. Some
compounds which have been shown to produce a
markedgeneralized phospholipidosis involvinglungs,
liver and endocrine tissues, peripheral and central
nerve cells, and epididymal tissue, have induced
only a mild degree of lipidosis in the retina. It
seems that the accummulation of myelinoid bodies
within the cell does not lead to cell death, and there
is some evidence that, even with the continued
administration ofcompounds, the cellsrecoverfrom
the initial shock, and the accumulated myelinoid is
not progressive. Myelinoid bodiestend to disappear
after cessation of treatment. The use of electron
microscopy is essential to look for these myelinoid
bodies. Myelin figures can be produced in tissues
fixed in glutaraldehyde, if fixation is prolonged.
These figures could be mistaken for pathological
change.
Some chemicals cause a loss oftapetal color. The
change first appears as patchy fading ofthe tapetal
color, until eventually the entire tapetum has a
bleached appearance. No histological change can be
FIGURE 8. Tapetal cells for animals with a bleached tapeta. x 20,200.
Environmental Health Perspectives 42detected by light microscopy, but electron micros-
copy shows the presence of ultrastructural chang-
es. Tapetal cells from normal dogs are character-
ized by the presence ofparallel groups ofuniformly
dense intracytoplasmic rods (Fig. 7): in animals
with bleached tapeta the parallel arrangement of
the rods is disrupted, the rods are surrounded by
vacuoles which are not uniformly dense, appearing
swollen with indistinct outlines (Fig. 8). No func-
tional alteration can be detected by ERG otherthan
slight prolongation ofthe implicit time ofthe wave
forms evoked in response to low-intensity stimuli in
the dark-adapted state. These changes are attrib-
uted to the chelating action of these compounds;
ethambutol is one such compound (30).
Clinical and functional examinations ofthe retina
are showntohaveconsiderablelimitations indetect-
ingtoxicity. Histologicalexaminationofthicksections
will detect only the most gross lesion. The use of
electron microscopy is essential to look for chemi-
cally induced side effects at the cellular level.
Optic Nerve
The response ofthe optic nerve is limited: it may
show atrophy or it may increase in size. The cases
ofatrophy show as a reduction ofmyelinated axons
or demyelination ofthe optic nerve. In the dog, an
organophosphate pesticide-ethylthiometon (31)-
and clioquinol (32) inducethistype ofchange. Etham-
butol has caused demyelination of the optic nerve,
chiasm and tract in the monkey (33) and the rat
(34).
Edema of the disc is reported in monkeys with
methyl alcohol poisoning (35) and trimethyltin ace-
tate (36). Salicylanilide (37) causes vacuolation of
the cerebral white matter in the dog and edema of
the disc (Fig. 9), and hexachlorophene (38) induces
peripapillary exudations in the dog.
Changes in the optic nerve are readily diagnosed
by the standard clinical and histopathological meth-
ods, although impairment of the pupillary light
reflex is frequently the first evidence of damage.
Discussion
The validity ofsafety evaluations is based on the
assumption that extrapolation from animal to man
is possible. It is appropriate to ask how predictive
are the common laboratory animal species with
respect to ocular toxicity.
In a recent survey, in which the toxicological
profile of 50 compounds were compared in rodent
and nonrodent species, Keywood (39) found that in
the dog, 26% ofthe compounds and, in the monkey
species, 7% of the compounds, induced some form
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of ocular toxicity, whereas in the rodent, none of
the compounds affected the eye. A review of the
literature shows some correlations for ocular toxic-
ity between the rodent and nonrodent species-for
example, triparanol, somesulfonamides, chloroquine,
iminodipropionitrile -butsuchcorrelationsarerare.
If we try to compare adverse eye reactions in
man with toxic findings in animals, again the corre-
lations are poor. The classical cataractogenic agent
cited for man is dinitrophenol. Animal models to
investigate the cataractogenicity of this drug have
been the duck or chicken, special strains of mice,
scorbutic guinea pigs, rabbits under 1 month, or
3-week old dogs. It is apparent that current safety
evaluation studies in rats and beagle dogs or non-
human primates would not have predicted the
cataractogenic potential of this compound to man.
Cortical posterior subcapsular cataracts have been
induced in man, both in children and adults, by a
varietyofglucocorticoids. Animalexperimentshave
failed to induce changes in the lens. The keratocon-
junctivitis sicca described by Wright (40) as part of
FIGURE 9. Edema of the disc: dog.
43the mucocutaneous syndrome induced by practolol,
was not predicted by conventional animal experi-
mentation. Attempts to reproduce subacute myelo-
optic neuropathy (SMON) in experimental animals
has yielded unreliable and sometimes equivocal
results. Worden and Heywood (41) drew attention
tothe fact that the lesion induced in the dog did not
accord with the criteria for SMON in man.
Somefindingsinanimals, have notbeenconfirmed
by human clinical experience. In aging monkeys,
both controls and particularly animals undergoing
long-term administration with progestogens, hyper-
fluorescent spots around the macula have been
described. Fine and Kwapien (42) have shown that
these lesions consist almost exclusively of lipoid
degeneration of the pigment epithelial cells. The
significance of this finding in relation to women
using oral contraceptives is not known; however,
there is no clinical evidence to establish an adverse
effect oforal contraceptives onthe retina. Fromthe
datapresented it would appear that all amphophilic
cationic compounds have the potential to affect Lhe
retina in the rat, and form myelinoid bodies. The
same mechanism is evidently not operant in man.
Many compounds affect physiological processes
which may involve the visual system but which
cannot be predicted from animal experimentation.
Of 56 compounds investigated by Laroche and
Laroche (43), 34 were found to decrease color dis-
crimination significantly; 18 ofthese 56 compounds
were antibiotics, and nine caused some impairment
of vision. Of patients on digitalis, 10-25% experi-
ence some visual symptom of toxicity (4). The hal-
lucinogens have variable effects on vision (44).
The eye may show side effects from a wide vari-
ety ofdrugs used in clinical medicine. Some ofthese
sideeffects, althoughundesirable, mustbeaccepted
as unavoidable. Many ofthe ocular side effects are
caused by overdosage or indirect consequences of
the drugs' primary action, or by an individual idio-
syncracy.
Target-organ toxicity, induced by high dose lev-
els of test compound in laboratory animals, is of
little importance in the assessment of safety of
compounds. Safety evaluation should be based on
the no observable effect level. As far as the eye is
concerned, animal experiments have been shown to
have little predictive value for man.
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